These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11972486

  • 1. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population.
    Bucková D, Izakovicová Hollá L, Vácha J.
    Allergy; 2002 May; 57(5):446-8. PubMed ID: 11972486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L.
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.
    Lampalo M, Jukic I, Bingulac-Popovic J, Marunica I, Petlevski R, Pavlisa G, Popovic-Grle S.
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

  • 8. The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype.
    Lampalo M, Jukić I, Bingulac-Popović J, Safić H, Ferara N, Popović-Grle S.
    Acta Clin Croat; 2018 Mar; 57(1):96-102. PubMed ID: 30256016
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E, Soylar R, Arıkan-Ayyıldız Z, Uzuner N, Giray-Bozkaya Ö, Erçal D, Karaman Ö, Ülgenalp A.
    Allergol Immunopathol (Madr); 2013 Mar; 41(1):11-6. PubMed ID: 22361338
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z, Jhun B, Jung SY, Oh CK.
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [Abstract] [Full Text] [Related]

  • 12. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
    Bang CO, Park HK, Ahn MY, Shin HK, Hwang KY, Hong SY.
    Cerebrovasc Dis; 2001 Apr; 11(4):294-9. PubMed ID: 11385207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 17. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan 01; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Jan 01; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 19. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 Jan 01; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 20. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.
    Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M.
    Lancet; 1999 Aug 14; 354(9178):556-60. PubMed ID: 10470700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.